Exercise-induced cardioprotection is impaired by anabolic steroid treatment through a redox-dependent mechanism

•Supraphysiological DECA treatment on heart redox metabolism was investigated during I/R in sedentary and exercised rats.•DECA reduced SOD and GR activities in exercised rats upon reperfusion.•Reduced antioxidant enzyme activities promote heart thiol oxidation in exercised rats.•Anabolic androgenic...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of steroid biochemistry and molecular biology Vol. 138; pp. 267 - 272
Main Authors Chaves, Elen A., Fortunato, Rodrigo S., Carvalho, Denise P., Nascimento, José Hamilton M., Oliveira, Marcus F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Supraphysiological DECA treatment on heart redox metabolism was investigated during I/R in sedentary and exercised rats.•DECA reduced SOD and GR activities in exercised rats upon reperfusion.•Reduced antioxidant enzyme activities promote heart thiol oxidation in exercised rats.•Anabolic androgenic steroid abuse cardiotoxicity involves redox imbalance in exercised animals. High doses of anabolic androgenic steroids (AAS) impair the cardioprotective effects of exercise against ischemia/reperfusion (I/R) insult, possibly through cellular redox imbalance. Here, the effect of nandrolone decanoate (DECA) treatment on heart redox metabolism was investigated during I/R in sedentary and exercised rats. DECA treatment significantly reduced superoxide dismutase and glutathione reductase activities in exercised rats after heart reperfusion. Catalase and glutathione peroxidase activities were not affected by DECA in both sedentary and trained rats, regardless the I/R period. DECA also induced myocardial oxidative stress, as evidenced by the reduced levels of total reduced thiols after heart reperfusion in exercised rats treated with the anabolic steroid. These results indicate that cardiotoxic effects of supraphysiological doses of AAS involve reduced heart antioxidant capacity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-0760
1879-1220
DOI:10.1016/j.jsbmb.2013.06.006